Charlie’s Holdings Applauds Recent CDC Findings in Vape Market

Positive news from the CDC confirms that legal nicotine-only e-liquid vapes were not involved in recent vape crisis

COSTA MESA, CA / ACCESSWIRE / January 9, 2020 / Charlie’s Holdings, Inc. (OTC PINK:CHUC) (“Charlie’s” or the “Company), an industry leader in both the premium, nicotine-only, e-liquid space and the hemp-derived, CBD wellness space, applauds the recent findings by the Centers for Disease Control and Prevention (CDC) indicating that vitamin E acetate is behind the ‘vast majority’ of vaping illnesses. (https://www.yahoo.com/lifestyle/cdc-confirms-vitamin-e-acetate-is-causing-vast-majority-of-vaping-illnesses-heres-what-else-we-learned-174356096.html)

The Company supports customer-centric regulation in the vape industry that protects consumers while ensuring consumer choice. Charlie’s Holdings is a pioneer in the nicotine e-liquid space, with a reputation for high-quality brands and products. The Company appreciates the hard work of the team at the CDC, and supports appropriate regulatory changes that enhance consumer safety. Charlie’s Holdings continues to lead the nicotine-only e-liquid industry through innovative flavors, products and brands, safely distributed through vape shops worldwide.

“We are encouraged by recent news from the CDC, confirming the primary cause behind the vape crisis is vitamin E acetate, commonly found in illegal counterfeit THC vapes. Our products do not contain unsafe fillers, and are only sold through legal vape shops. Our strong sales during this crisis are a powerful indicator of the confidence our customers and the industry have in Charlie’s Chalk Dust. We anticipate continued growth in the new year, already supported by growing distribution overseas.”, stated Brandon Stump, Chief Executive Officer of Charlie’s Holdings.

The following are highlights from the recent CDC announcement:

CDC confirms Vitamin E acetate is causing ‘vast majority’ of vaping illnesses – here’s what else we learned

EVALI is the name given to vaping-related illness in E-cigarette, or Vaping, product use Associated Lung Injury.

CDC has analyzed national data on use of THC-containing product brands by EVALI patients.

  • Overall, 152 different THC-containing product brands were reported by EVALI patients.
  • Black market vaping products are the most dangerous.
  • Dank Vapes, a class of largely counterfeit THC-containing products of unknown origin, was the most commonly reported product brand used by patients nationwide, although there are regional differences. While Dank Vapes was most commonly reported in the Northeast and South, TKO and Smart Cart brands were more commonly reported by patients in the West and Rove was more common in the Midwest.
  • The data further supports that EVALI is associated with THC-containing products and that it is not likely associated with a single THC-containing product brand.
  • Diluting vapes with vitamin E acetate started in 2019.
  • The CDC has confirmed that vitamin E acetate is fueling more than 2,500 hospitalizations nationwide.

About Charlie’s Holdings, Inc.

Charlie’s Holdings, Inc. (OTC Pink: CHUC) is an industry leader in both the premium, nicotine-only, e-cigarette space and the hemp-derived, CBD wellness space through its subsidiary companies Charlie’s Chalk Dust, LLC and Don Polly, LLC. Charlie’s Chalk Dust produces high quality vapor products currently distributed in more than 90 countries around the world. Charlie’s Chalk Dust has developed an extensive portfolio of brand styles, flavor profiles and innovative product formats. Launched in June of 2019, Don Polly, LLC formulates innovative hemp-derived CBD wellness products. Don Polly’s high-quality CBD products derive from single-strain-sourced hemp extract and high purity CBD isolate crystals.

For additional information, please visit our corporate website at: CharliesHoldings.com and our branded online websites: CharliesChalkDust and EnjoyPachamama.

Safe Harbor Statement

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company’s overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ability to successful increase sales and enter new markets; the Company’s ability to manufacture and produce product for its customers; the Company’s ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine and products containing cannabidiol; litigation risks from the use of the Company’s products; risks of government regulations; the impact of competitive products; and the Company’s ability to maintain and enhance its brand, as well as other risk factors included in the Company’s most recent quarterly report on Form 10-Q and other SEC filings. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

Investors Contact:

IR@charliesholdings.com
p949-418-4020

SOURCE: Charlie’s Holdings, Inc.

View source version on accesswire.com:
https://www.accesswire.com/572568/Charlies-Holdings-Applauds-Recent-CDC-Findings-in-Vape-Market

error: Content is protected !!